Please do not leave this page until complete. This can take a few moments.
Reducing federal spending is generally a popular measure among the American public. But dig into the minutiae and the picture gets complicated.
Psychemedics Corp. of Acton posted record revenue of $6.9 million for the second quarter, the company announced. That's a 10-percent increase from the same quarter last year for the company that produces hair tests for drug abuse.
Advanced Cell Technology (ACT) of Marlborough, a biotechnology firm working in regenerative medicine, reported increased revenue for the second quarter, thanks to license fees and royalty payments.
Nuclea Biotechnologies Inc., which has operations in Worcester, announced that it has closed its first Series C funding round, raising $5 million.
Waltham-based Thermo Fisher Scientific, which has operations in Franklin and Milford, reported record second-quarter revenue of $3.1 billion. That represented an increase of 8.7 percent over the second quarter of 2011.
The cost of LED bulbs will decrease by half by the end of the decade, thanks to technology advances, according to Boston-based Lux Research.
The efforts to turn Central Massachusetts into a life sciences epicenter to rival — or depending who you talk to, complement — Cambridge and Boston have been well underway for decades.
Holliston-based Harvard Bioscience rolled out a bioreactor in 2010 that's now playing a vital role in the world's first transplants of synthetic and regenerated windpipes in humans.
The federal Department of Energy has awarded three Central Massachusetts companies grants worth up to $1 million each to develop new energy technologies.
When higher education and manufacturers collide, innovation can result.
Seven biopharmaceutical firms, including Marlborough-based Sunovion Pharmaceuticals, will join to form the Massachusetts Neuroscience Consortium.
Acton-based drug test maker Psychemedics Corp. announced it has received clearance from the Food & Drug Administration (FDA) for five new, additional screening assays to test for the detection of illegal drugs.
Waltham-based PerkinElmer Inc. said it plans to establish a new research center at its recently acquired Caliper Life Sciences facility in Hopkinton.
Natick-based Boston Scientific Corp. announced it has received regulatory approval from the U.S. Food and Drug Administration (FDA) for two different lengths of its Promus Element stent, which is used to treat coronary artery disease patients.
Maynard-based career search website Monster.com found a wide gap in how employers view military veterans' civilian workforce skills and how veterans themselves view their skills.